Tataru, Christine
Peras, Marie
Rutherford, Erica
Dunlap, Kaiti
Yin, Xiaochen
Chrisman, Brianna S.
DeSantis, Todd Z.
Wall, Dennis P.
Iwai, Shoko
David, Maude M.
Funding for this research was provided by:
Larry W. Martin & Joyce B. O’Neill Endowed Fellowship
NBLational Institutes of Health (NIDA R44DA04395402)
Article History
Received: 12 October 2022
Accepted: 5 July 2023
First Online: 13 July 2023
Competing interests
: MP, ER, XY, TZD, SI, and MMD have a financial interest in Second Genome Inc, an independent therapeutics company with products in development to treat Inflammatory Bowel Diseases and Cancer, and could potentially benefit from the outcomes of this research. MMD is co-owner of NeuroBiome, LLC., a company specialized in developing biosensors. DPW is cofounder of Cognoa, a company focused on digital methods for healthy child development. CT and BC report no conflict of interest.